✦ LIBER ✦

Decrease of plasma taurine in Gaucher disease and its sustained correction during enzyme replacement therapy

✍ Scribed by S. vom Dahl; I. Mönnighoff; D. Häussinger

Book ID: 106222469
Publisher: Springer
Year: 2000
Tongue: English
Weight: 87 KB
Volume: 19
Category: Article
ISSN: 0939-4451
DOI: 10.1007/s007260070008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correction of neutrophil chemotaxis defe

Correction of neutrophil chemotaxis defect in patients with gaucher disease by low-dose enzyme replacement therapy

✍ Dr. A. Zimran; A. Abrahamov; M. Aker; Y. Matzner 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

We have recently described a chemotactic defect in severely afflicted Gaucher disease patients. Two of the patients were treated with low-dose intravenous enzyme replacement (Ceredase). Marked improvement in their hematological status, organomegaly, and growth was observed. In addition, their chemot

Value of plasma chitotriosidase to asses

Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy

✍ van Dussen, L.; Hendriks, E. J.; Groener, J. E. M.; Boot, R. G.; Hollak, C. E. M 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 517 KB

Improvement of bone disease with increas

Improvement of bone disease with increased dose of glucocerebrosidase in a Gaucher disease patient who had a bone lesion presenting during low-dose enzyme replacement therapy

✍ TAKAHIRO UEDA; YOSHITAKA FUKUNAGA; MAKOTO MIGITA; ATSUSHI WATANABE; KIYOSHI KANE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Lung involvement of Egyptian children wi

Lung involvement of Egyptian children with type 1 and 3 Gaucher disease: does enzyme replacement therapy have a role in reversing symptoms and can it be considered an index of disease severity?

✍ Abdelwahab, Magy; Seif, Hadeel; Hesham, Rania 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 171 KB